Tetratherix Limited (ASX:TTX)
Australia · Delayed Price · Currency is AUD 3.790
-0.110 (-2.82%)
Feb 19, 2026, 3:59 PM AEST
Tetratherix Market Cap
Tetratherix has a market cap or net worth of 197.99 million as of February 18, 2026.
Market Cap
197.99M
Enterprise Value
170.69M
Revenue
1.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.79
Market Cap Chart
Since June 30, 2025, Tetratherix's market cap has increased from 152.00M to 197.99M, an increase of 30.25%. That is a compound annual growth rate of 51.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 197.99M | 19.93% |
| Dec 30, 2025 | 165.09M | 8.61% |
| Jun 30, 2025 | 152.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Racura Oncology | 390.30M |
| Dimerix | 297.20M |
| Orthocell | 249.60M |
| Botanix Pharmaceuticals | 221.64M |
| Starpharma Holdings | 209.96M |
| Recce Pharmaceuticals | 170.62M |
| Actinogen Medical | 145.40M |
| Paradigm Biopharmaceuticals | 130.10M |